论文信息 - Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle‐invasive bladder cancer - 字舞流文

Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle‐invasive bladder cancer

M. Mazumdar | T. Powles | E. Plimack | M. Galsky | J. Rosenberg | N. Waingankar | J. Sfakianos | R. Mehrazin | R. Jia | B. Ferket | A. Martini | A. Necchi | S. Crabb | E. Yu | L. Harshman | S. Pal | U. Vaishampayan | N. Wiklund | N. P. Wiklund | J. Rosenberg | Bart S. Ferket | Evan Y. Yu